Rhakoss Spinal Implant May Be Safer Alternative To Allograft – Orthovita
This article was originally published in The Gray Sheet
Executive Summary
Orthovita is emphasizing its Rhakoss synthetic bone spinal implant as a potentially safer alternative to allograft for cervical spinal fusion surgery
You may also be interested in...
Orthovita Rhakoss
Orthopedic biomaterials manufacturer plans to file for a CE mark by year end, following completed enrollment of 70 cervical spinal fusion patients in a nine-site pivotal trial. Patients will be followed for six months. The synthetic bone spinal implant is a potentially safer alternative to allograft for cervical spinal fusion surgery, Orthovita contends (1"The Gray Sheet" Aug. 26, 2002, p. 28)...
Orthovita Rhakoss
Orthopedic biomaterials manufacturer plans to file for a CE mark by year end, following completed enrollment of 70 cervical spinal fusion patients in a nine-site pivotal trial. Patients will be followed for six months. The synthetic bone spinal implant is a potentially safer alternative to allograft for cervical spinal fusion surgery, Orthovita contends (1"The Gray Sheet" Aug. 26, 2002, p. 28)...
Orthovita Cortoss
Synthetic cortical bone void filler receives CE mark for vertebral augmentation, including compression fractures caused by osteoporosis and invasive tumors. Patient enrollment for a 20-patient, U.S. pilot trial assessing Cortoss for vertebral augmentation began early this year. Advantages over PMMA bone cement include improved visualization and reduced risk of thermal tissue damage (1"The Gray Sheet" Aug. 26, 2002, p. 28)...